GSK (LON:GSK) Share Price Crosses Above Two Hundred Day Moving Average - Time to Sell?

Key Points

• GSK's stock price has recently surpassed its 200-day moving average of GBX 1,430.92, currently trading at GBX 1,518 ($20.39).
• Analysts have mixed ratings on GSK, with one "Buy," two "Hold," and one "Sell" rating, leading to an average target price of GBX 1,637.50.
• Insider activity includes recent purchases by Wendy Becker, who bought 526 shares, indicating potential confidence in the stock among company insiders.

GSK plc (LON:GSK - Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 1,430.92 ($19.22) and traded as high as GBX 1,544.16 ($20.74). GSK shares last traded at GBX 1,518 ($20.39), with a volume of 10,963,115 shares changing hands.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on GSK. Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a GBX 1,450 target price on shares of GSK in a research report on Thursday, July 31st. Berenberg Bank reiterated a "hold" rating and issued a GBX 1,600 price objective on shares of GSK in a research report on Friday, July 18th. JPMorgan Chase & Co. decreased their price objective on shares of GSK from GBX 1,460 to GBX 1,400 and set an "underweight" rating for the company in a research report on Monday, August 4th. Finally, Shore Capital reiterated a "buy" rating and issued a GBX 2,100 price objective on shares of GSK in a research report on Wednesday, August 27th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of GBX 1,637.50.

GSK Stock Performance

The company has a current ratio of 0.81, a quick ratio of 0.73 and a debt-to-equity ratio of 114.64. The firm's 50-day moving average is GBX 1,447.12 and its two-hundred day moving average is GBX 1,430.92. The stock has a market cap of £61.58 billion, a price-to-earnings ratio of 1,848.85, a P/E/G ratio of 1.24 and a beta of 0.31.

GSK (LON:GSK - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported GBX 75.30 earnings per share for the quarter. GSK had a net margin of 8.02% and a return on equity of 18.08%. As a group, sell-side analysts expect that GSK plc will post 175.980975 earnings per share for the current year.

Insider Buying and Selling at GSK

In related news, insider Wendy Becker purchased 526 shares of GSK stock in a transaction that occurred on Friday, September 19th. The stock was purchased at an average price of GBX 1,503 per share, for a total transaction of £7,905.78. In the last three months, insiders have bought 561 shares of company stock worth $841,184. 0.20% of the stock is owned by corporate insiders.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.